NEOGEN CORP
About NEOGEN CORP
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $894.7M
- Net income
- -$1.1B
- Total assets
- $3.4B
- Market cap
- $1.9B
- Gross margin
- 47.1%
- Operating margin
- -118.6%
- Net margin
- -122.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $894.7M
- Cost of revenue
- $473.3M
- Gross profit
- $421.4M
- Operating expenses
- $1.5B
- Operating income
- -$1.1B
- Income tax
- -$41.1M
- Net income
- -$1.1B
- EPS (basic)
- $-5.03
- EPS (diluted)
- $-5.03
Balance sheet
- Total assets
- $3.4B
- Current assets
- $576.9M
- Total liabilities
- $1.4B
- Current liabilities
- $174.0M
- Shareholders’ equity
- $2.1B
Cash flow
- Operating cash flow
- $58.2M
- Investing cash flow
- -$99.2M
- Financing cash flow
- -$1.6M
- Net cash flow
- -$42.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.9B
- EPS (diluted)
- $-5.03
- Shares outstanding
- 213.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 23, 1989
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $1.1B in FY2025.
- Revenue grew 91% from FY2021 to FY2025.
- Gross margin of 47.1%, net margin -122.1%.
- Trading 20% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NEOGEN CORP.
Write a review
News about NEOGEN CORP
News & sentiment via Polygon.io
